Drug intelligence / Profile preview

Shuangbai San

Development stage: Phase 1
Lead developer: Guangzhou University of Chinese Medicine
Administration: Topical

Overview

Shuangbai San is a traditional Chinese medicine (TCM) herbal formula used externally for the management of pain, swelling, and inflammation. It is composed of five major herbal ingredients: Rhei Radix Et Rhizoma (Dahuang), Platycladi Cacumen (Cebaiye), Phellodendri Cortex (Huangbai), Herba Lycopi (Zeran), and Mentha haplocalyx (Bohe). Shuangbai San is widely used in surgical and orthopedic settings in China for conditions such as sprains, soft tissue injuries, and acute gouty arthritis. Additionally, clinical studies, including a multicenter randomized trial led by the Guangzhou University of Chinese Medicine, have evaluated its efficacy and safety as a topical treatment for cancer-related pain in patients with primary liver cancer.

Other names: Shuangbai San pasteShuangbai powderShuangbai-powdershuangbai san

Beyond the preview

Go deeper on Shuangbai San.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shuangbai San.